Pro-Dex, Inc. (PDEX)
USD 45.73
(-5.61%)
USD 45.73
(-5.61%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 7.37 Million USD | 5.6% |
| 2023 | 6.98 Million USD | -12.38% |
| 2022 | 7.97 Million USD | -11.89% |
| 2021 | 9.05 Million USD | 48.82% |
| 2020 | 6.08 Million USD | 26.98% |
| 2019 | 4.78 Million USD | 5.53% |
| 2018 | 4.53 Million USD | 4.59% |
| 2017 | 4.33 Million USD | -6.33% |
| 2016 | 4.63 Million USD | 0.56% |
| 2015 | 4.6 Million USD | 21.85% |
| 2014 | 3.78 Million USD | -32.63% |
| 2013 | 5.61 Million USD | -17.25% |
| 2012 | 6.78 Million USD | -7.01% |
| 2011 | 7.29 Million USD | 1.99% |
| 2010 | 7.15 Million USD | -1.28% |
| 2009 | 7.24 Million USD | -6.58% |
| 2008 | 7.75 Million USD | 18.82% |
| 2007 | 6.52 Million USD | 20.17% |
| 2006 | 5.43 Million USD | 13.41% |
| 2005 | 4.78 Million USD | -3.7% |
| 2004 | 4.97 Million USD | 7.88% |
| 2003 | 4.6 Million USD | -26.08% |
| 2002 | 6.23 Million USD | -21.8% |
| 2001 | 7.97 Million USD | -26.28% |
| 2000 | 10.81 Million USD | -42.57% |
| 1999 | 18.83 Million USD | 67.5% |
| 1998 | 11.24 Million USD | 3.15% |
| 1997 | 10.9 Million USD | 3.81% |
| 1996 | 10.5 Million USD | 84.21% |
| 1995 | 5.7 Million USD | 16.33% |
| 1994 | 4.9 Million USD | 44.12% |
| 1993 | 3.4 Million USD | -2.86% |
| 1992 | 3.5 Million USD | 400.0% |
| 1991 | 700 Thousand USD | 16.67% |
| 1990 | 600 Thousand USD | -14.29% |
| 1989 | 700 Thousand USD | -58.82% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 1.89 Million USD | -6.62% |
| 2024 Q2 | 2.02 Million USD | 10.96% |
| 2024 Q1 | 1.82 Million USD | 4.35% |
| 2024 FY | 7.64 Million USD | 9.42% |
| 2024 Q4 | 1.84 Million USD | -2.54% |
| 2023 Q2 | 1.48 Million USD | -25.92% |
| 2023 Q4 | 1.74 Million USD | 0.17% |
| 2023 Q1 | 2 Million USD | -10.41% |
| 2023 FY | 6.98 Million USD | -12.38% |
| 2023 Q3 | 1.74 Million USD | 17.5% |
| 2022 Q1 | 2.11 Million USD | -16.57% |
| 2022 Q4 | 2.23 Million USD | 22.82% |
| 2022 Q3 | 1.82 Million USD | 1.17% |
| 2022 Q2 | 1.8 Million USD | -14.6% |
| 2022 FY | 7.97 Million USD | -11.89% |
| 2021 Q1 | 1.92 Million USD | -7.85% |
| 2021 Q2 | 2.07 Million USD | 7.74% |
| 2021 Q4 | 2.52 Million USD | 0.36% |
| 2021 Q3 | 2.52 Million USD | 21.45% |
| 2021 FY | 9.05 Million USD | 48.82% |
| 2020 FY | 6.08 Million USD | 26.98% |
| 2020 Q3 | 1.5 Million USD | 25.92% |
| 2020 Q2 | 1.19 Million USD | -7.21% |
| 2020 Q1 | 1.28 Million USD | -5.29% |
| 2020 Q4 | 2.09 Million USD | 38.78% |
| 2019 Q3 | 1.36 Million USD | 29.36% |
| 2019 FY | 4.78 Million USD | 5.53% |
| 2019 Q4 | 1.36 Million USD | -0.37% |
| 2019 Q1 | 1 Million USD | -4.64% |
| 2019 Q2 | 1.05 Million USD | 4.97% |
| 2018 Q2 | 1.14 Million USD | 14.33% |
| 2018 Q4 | 1.05 Million USD | -21.5% |
| 2018 Q3 | 1.34 Million USD | 17.79% |
| 2018 FY | 4.53 Million USD | 4.59% |
| 2018 Q1 | 998 Thousand USD | -14.48% |
| 2017 Q3 | 1.11 Million USD | 6.91% |
| 2017 Q4 | 1.16 Million USD | 4.76% |
| 2017 FY | 4.33 Million USD | -6.33% |
| 2017 Q1 | 1.2 Million USD | -3.61% |
| 2017 Q2 | 1.04 Million USD | -13.31% |
| 2016 FY | 4.63 Million USD | 0.56% |
| 2016 Q4 | 1.24 Million USD | 17.09% |
| 2016 Q2 | 1.14 Million USD | -2.81% |
| 2016 Q3 | 1.06 Million USD | -6.82% |
| 2016 Q1 | 1.17 Million USD | 10.53% |
| 2015 FY | 4.6 Million USD | 21.85% |
| 2015 Q1 | 1.01 Million USD | 7.39% |
| 2015 Q2 | 1.08 Million USD | 7.08% |
| 2015 Q4 | 1.06 Million USD | -25.85% |
| 2015 Q3 | 1.43 Million USD | 31.77% |
| 2014 FY | 3.78 Million USD | -32.63% |
| 2014 Q4 | 947 Thousand USD | -3.17% |
| 2014 Q3 | 978 Thousand USD | 5.73% |
| 2014 Q2 | 925 Thousand USD | 0.11% |
| 2014 Q1 | 924 Thousand USD | -26.49% |
| 2013 FY | 5.61 Million USD | -17.25% |
| 2013 Q3 | 1.65 Million USD | 17.06% |
| 2013 Q2 | 1.41 Million USD | 9.7% |
| 2013 Q1 | 1.28 Million USD | -22.36% |
| 2013 Q4 | 1.25 Million USD | -24.0% |
| 2012 Q3 | 1.87 Million USD | 11.28% |
| 2012 FY | 6.78 Million USD | -7.01% |
| 2012 Q4 | 1.65 Million USD | -11.52% |
| 2012 Q2 | 1.68 Million USD | -9.99% |
| 2012 Q1 | 1.87 Million USD | -2.35% |
| 2011 FY | 7.29 Million USD | 1.99% |
| 2011 Q1 | 1.77 Million USD | -6.47% |
| 2011 Q2 | 1.85 Million USD | 4.16% |
| 2011 Q3 | 1.74 Million USD | -5.88% |
| 2011 Q4 | 1.91 Million USD | 9.92% |
| 2010 Q3 | 1.88 Million USD | 8.97% |
| 2010 Q4 | 1.9 Million USD | 1.01% |
| 2010 Q2 | 1.72 Million USD | 5.56% |
| 2010 FY | 7.15 Million USD | -1.28% |
| 2010 Q1 | 1.63 Million USD | -4.32% |
| 2009 Q1 | 1.91 Million USD | -15.11% |
| 2009 Q2 | 1.83 Million USD | -3.72% |
| 2009 FY | 7.24 Million USD | -6.58% |
| 2009 Q3 | 1.78 Million USD | -3.1% |
| 2009 Q4 | 1.71 Million USD | -3.98% |
| 2008 FY | 7.75 Million USD | 18.82% |
| 2008 Q2 | 1.85 Million USD | 13.47% |
| 2008 Q3 | 2.01 Million USD | 8.9% |
| 2008 Q4 | 2.25 Million USD | 11.5% |
| 2008 Q1 | 1.63 Million USD | 9.6% |
| 2007 Q4 | 1.49 Million USD | -17.45% |
| 2007 Q1 | 1.55 Million USD | 5.86% |
| 2007 FY | 6.52 Million USD | 20.17% |
| 2007 Q2 | 1.66 Million USD | 7.14% |
| 2007 Q3 | 1.8 Million USD | 8.41% |
| 2006 Q4 | 1.46 Million USD | 1.45% |
| 2006 Q3 | 1.44 Million USD | 17.45% |
| 2006 Q2 | 1.23 Million USD | -3.98% |
| 2006 Q1 | 1.28 Million USD | 27.28% |
| 2006 FY | 5.43 Million USD | 13.41% |
| 2005 FY | 4.78 Million USD | -3.7% |
| 2005 Q1 | 1.16 Million USD | -6.89% |
| 2005 Q2 | 1.31 Million USD | 13.25% |
| 2005 Q3 | 1.3 Million USD | -1.06% |
| 2005 Q4 | 1 Million USD | -22.58% |
| 2004 Q3 | 1.2 Million USD | -8.37% |
| 2004 Q2 | 1.31 Million USD | 8.96% |
| 2004 Q4 | 1.24 Million USD | 3.65% |
| 2004 FY | 4.97 Million USD | 7.88% |
| 2004 Q1 | 1.2 Million USD | 7.97% |
| 2003 Q1 | 1.15 Million USD | -44.93% |
| 2003 FY | 4.6 Million USD | -26.08% |
| 2003 Q4 | 1.11 Million USD | 4.0% |
| 2003 Q3 | 1.07 Million USD | -15.17% |
| 2003 Q2 | 1.26 Million USD | 9.9% |
| 2002 Q3 | 1.27 Million USD | -12.11% |
| 2002 Q4 | 2.09 Million USD | 63.82% |
| 2002 FY | 6.23 Million USD | -21.8% |
| 2002 Q1 | 1.41 Million USD | 228.2% |
| 2002 Q2 | 1.45 Million USD | 2.76% |
| 2001 Q2 | 3.72 Million USD | 45.54% |
| 2001 Q3 | 2.79 Million USD | -24.99% |
| 2001 FY | 7.97 Million USD | -26.28% |
| 2001 Q4 | -1.1 Million USD | -139.49% |
| 2001 Q1 | 2.55 Million USD | -18.18% |
| 2000 Q3 | 2.65 Million USD | -1.63% |
| 2000 FY | 10.81 Million USD | -42.57% |
| 2000 Q4 | 3.12 Million USD | 17.73% |
| 2000 Q2 | 2.7 Million USD | 17.39% |
| 2000 Q1 | 2.3 Million USD | -75.62% |
| 1999 Q2 | 3 Million USD | -14.29% |
| 1999 Q4 | 9.43 Million USD | 214.43% |
| 1999 Q3 | 3 Million USD | 0.0% |
| 1999 Q1 | 3.5 Million USD | 27.57% |
| 1999 FY | 18.83 Million USD | 67.5% |
| 1998 FY | 11.24 Million USD | 3.15% |
| 1998 Q1 | 2.8 Million USD | 3.7% |
| 1998 Q2 | 3 Million USD | 7.14% |
| 1998 Q3 | 2.8 Million USD | -6.67% |
| 1998 Q4 | 2.74 Million USD | -2.02% |
| 1997 Q4 | 2.7 Million USD | -10.0% |
| 1997 Q2 | 2.6 Million USD | -7.14% |
| 1997 Q1 | 2.8 Million USD | 7.69% |
| 1997 Q3 | 3 Million USD | 15.38% |
| 1997 FY | 10.9 Million USD | 3.81% |
| 1996 Q1 | 2.1 Million USD | 61.54% |
| 1996 Q3 | 3.1 Million USD | 14.81% |
| 1996 FY | 10.5 Million USD | 84.21% |
| 1996 Q4 | 2.6 Million USD | -16.13% |
| 1996 Q2 | 2.7 Million USD | 28.57% |
| 1995 Q3 | 1.4 Million USD | -6.67% |
| 1995 Q4 | 1.3 Million USD | -7.14% |
| 1995 Q2 | 1.5 Million USD | -25.0% |
| 1995 Q1 | 2 Million USD | -16.67% |
| 1995 FY | 5.7 Million USD | 16.33% |
| 1994 Q2 | 800 Thousand USD | 0.0% |
| 1994 Q3 | 900 Thousand USD | 12.5% |
| 1994 Q4 | 2.4 Million USD | 166.67% |
| 1994 FY | 4.9 Million USD | 44.12% |
| 1994 Q1 | 800 Thousand USD | -50.0% |
| 1993 Q3 | 600 Thousand USD | -45.45% |
| 1993 FY | 3.4 Million USD | -2.86% |
| 1993 Q4 | 1.6 Million USD | 166.67% |
| 1993 Q1 | 1 Million USD | 42.86% |
| 1993 Q2 | 1.1 Million USD | 10.0% |
| 1992 Q3 | 1 Million USD | 0.0% |
| 1992 FY | 3.5 Million USD | 400.0% |
| 1992 Q4 | 700 Thousand USD | -30.0% |
| 1992 Q1 | - USD | 100.0% |
| 1992 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | 100.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 FY | 700 Thousand USD | 16.67% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q4 | -2.1 Million USD | 0.0% |
| 1990 Q4 | -1.9 Million USD | 0.0% |
| 1990 FY | 600 Thousand USD | -14.29% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q1 | - USD | 100.0% |
| 1990 Q3 | - USD | 0.0% |
| 1989 Q4 | -2.1 Million USD | 0.0% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 FY | 700 Thousand USD | -58.82% |
| 1989 Q3 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | 92.924% |
| AngioDynamics, Inc. | 252.41 Million USD | 97.077% |
| AtriCure, Inc. | 327.05 Million USD | 97.744% |
| Avinger, Inc. | 18.63 Million USD | 60.414% |
| Azenta, Inc. | 336.26 Million USD | 97.806% |
| BioLife Solutions, Inc. | 117.57 Million USD | 93.725% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 99.596% |
| Daxor Corporation | 1.28 Million USD | -476.174% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | 69.501% |
| Femasys Inc. | 15.2 Million USD | 51.462% |
| GlucoTrack, Inc. | 7.1 Million USD | -3.857% |
| Harvard Bioscience, Inc. | 58.58 Million USD | 87.405% |
| Hologic, Inc. | 1.34 Billion USD | 99.452% |
| ICU Medical, Inc. | 717.04 Million USD | 98.971% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 99.751% |
| KORU Medical Systems, Inc. | 26.1 Million USD | 71.74% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | 91.833% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 6282.906% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 6282.906% |
| Masimo Corporation | 867 Million USD | 99.149% |
| Microbot Medical Inc. | 9.85 Million USD | 25.134% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | 59.946% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 98.396% |
| Nephros, Inc. | 9.78 Million USD | 24.591% |
| NovoCure Limited | 613.92 Million USD | 98.798% |
| NEXGEL, Inc. | 4.09 Million USD | -80.127% |
| NEXGEL, Inc. | 4.09 Million USD | -80.127% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | 92.784% |
| OraSure Technologies, Inc. | 125.34 Million USD | 94.114% |
| Pulse Biosciences, Inc. | 43.57 Million USD | 83.068% |
| Predictive Oncology Inc. | 15.22 Million USD | 51.555% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | 13.425% |
| QuidelOrtho Corporation | 1.35 Billion USD | 99.456% |
| Repligen Corporation | 261.12 Million USD | 97.175% |
| Sanara MedTech Inc. | 61.12 Million USD | 87.93% |
| STAAR Surgical Company | 224.55 Million USD | 96.714% |
| Sharps Technology, Inc. | 10.12 Million USD | 27.143% |
| Utah Medical Products, Inc. | 13.26 Million USD | 44.363% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.589% |
| Jin Medical International Ltd. | 3.91 Million USD | -88.331% |